The suppression of thoc1 in cancer cell apoptosis mediated by activated macrophages is nitric oxide-dependent

Biochemical Pharmacology

Volumn 86, Issue 2, 2013, Pages 242-252

  Lin, Yong Shiang ^a,b   Lin, Chao Hsiung ^a   Huang, Li De ^c   Chao, Tung ^a   Kuo, Cheng Deng ^d   Hung, Ling Chien ^a   Wong, Fen Hwa ^a   Lin, Chun Cheng ^c   Fu, Shu Ling ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b ACADEMIA SINICA   (Taiwan)

^c NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Apoptosis; Glycolipid; Nitric oxide; Nrf2; Thoc1; TLR4 agonist

Indexed keywords

GLYCOLIPID; GLYCOLIPID CCL 34; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PROTEIN; PROTEIN BCL 2; THO COMPLEX 1 PROTEIN; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT RESPONSIVE ELEMENT; APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER CELL; COCULTURE; CONTROLLED STUDY; CYTOTOXICITY; DONOR; DOWN REGULATION; GENE MUTATION; GENE OVEREXPRESSION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

EID: 84884906435     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2013.05.009     Document Type: Article

References (37)

1. Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol 2005;17: 1-14.
2. Pfannes SD, Muller B, Korner S, Bessler WG, Hoffmann P. Induction of soluble antitumoral mediators by synthetic analogues of bacterial lipoprotein in bone marrow-derived macrophages from LPS-responder and -nonresponder mice. J Leukoc Biol 2001;69:590-7. (Pubitemid 32294844)
3. Baratin M, Ziol M, Romieu R, Kayibanda M, Gouilleux F, Briand P, et al. Regression of primary hepatocarcinoma in cancer-prone transgenic mice by local interferon-gamma delivery is associated with macrophages recruitment and nitric oxide production. Cancer Gene Ther 2001;8:193-202. (Pubitemid 32322259)
4. Bruns CJ, Shinohara H, Harbison MT, Davis DW, Nelkin G, Killion JJ, et al. Therapy of human pancreatic carcinoma implants by irinotecan and the oral immunomodulator JBT 3002 is associated with enhanced expression of inducible nitric oxide synthase in tumor-infiltrating macrophages. Cancer Res 2000;60:2-7. (Pubitemid 30058719)
5. Shi Q, Xiong Q, Wang B, Le X, Khan NA, Xie K. Influence of nitric oxide synthase II gene disruption on tumor growth and metastasis. Cancer Res 2000;60: 2579-83. (Pubitemid 30318227)
6. Blaise GA, Gauvin D, Gangal M, Authier S. Nitric oxide, cell signaling and cell death. Toxicology 2005;208:177-92. (Pubitemid 40187330)
7. Mocellin S, Bronte V, Nitti D. Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities. Med Res Rev 2007;27: 317-52. (Pubitemid 46668937)
8. Dhakshinamoorthy S, Long DJ. 2nd, Jaiswal AK. Antioxidant regulation of genes encoding enzymes that detoxify xenobiotics and carcinogens. Curr Top Cell Regul 2000;36:201-16.
9. Lee JM, Calkins MJ, Chan K, Kan YW, Johnson JA. Identification of the NF-E2- related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. J Biol Chem 2003;278:12029-38. (Pubitemid 36800179)
10. Dhakshinamoorthy S, Porter AG. Nitric oxide-induced transcriptional upregulation of protective genes by Nrf2 via the antioxidant response element counteracts apoptosis of neuroblastoma cells. J Biol Chem 2004;279: 20096-107. (Pubitemid 38623454)
11. Thangasamy A, Rogge J, Krishnegowda NK, Freeman JW, Ammanamanchi S. Novel function of transcription factor Nrf2 as an inhibitor of RON tyrosine kinase receptor-mediated cancer cell invasion. J Biol Chem 2011;286:32115-22.
12. Hayes JD, McMahon M. NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer. Trends Biochem Sci 2009;34:176-88.
13. Martin-Montalvo A, Villalba JM, Navas P, de Cabo R. NRF2, cancer and calorie restriction. Oncogene 2011;30:505-20.
14. Slocum SL, Kensler TW. Nrf2: control of sensitivity to carcinogens. Arch Toxicol 2011;85:273-84.
15. Stepkowski TM, Kruszewski MK. Molecular cross-talk between the NRF2/ KEAP1 signaling pathway, autophagy, and apoptosis. Free Radic Biol Med 2011;50:1186-95.
16. Strachan GD, Ostrow LA, Jordan-Sciutto KL. Expression of the fetal Alz-50 clone 1 protein induces apoptotic cell death. Biochem Biophys Res Commun 2005;336: 490-5. (Pubitemid 41267256)
17. Jain A, Lamark T, Sjottem E, Larsen KB, Awuh JA, Overvatn A, et al. p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. J Biol Chem 2010;285:22576-91.
18. Jin Z, Li Y, Pitti R, Lawrence D, Pham VC, Lill JR, et al. Cullin3-based polyubiquitination and p62-dependent aggregation of caspase-8 mediate extrinsic apoptosis signaling. Cell 2009;137:721-35.
19. Hung LC, Lin CC, Hung SK, Wu BC, Jan MD, Liou SH, et al. A synthetic analog of alpha-galactosylceramide induces macrophage activation via the TLR4-signaling pathways. Biochem Pharmacol 2007;73:1957-70.
20. Huang LD, Lin HJ, Huang PH, Hsiao WC, Reddy LV, Fu SL, et al. Synthesis of serine-based glycolipids as potential TLR4 activators. Org Biomol Chem 2011;9:2492-504.
21. Lin YS, Huang LD, Lin CH, Huang PH, Chen YJ, Wong FH, et al. In vitro and in vivo anticancer activity of a synthetic glycolipid as Toll-like receptor 4 (TLR4) activator. J Biol Chem 2011;286:43782-92.
22. Li Y, Wang X, Zhang X, Goodrich DW. Human hHpr1/p84/Thoc1 regulates transcriptional elongation and physically links RNA polymerase II and RNA processing factors. Mol Cell Biol 2005;25:4023-33. (Pubitemid 40617651)
23. Dominguez-Sanchez MS, Saez C, Japon MA, Aguilera A, Luna R. Differential expression of THOC1 and ALY mRNP biogenesis/export factors in human cancers. BMC Cancer 2011;11:77.
24. Guo S, Hakimi MA, Baillat D, Chen X, Farber MJ, Klein-Szanto AJ, et al. Linking transcriptional elongation and messenger RNA export to metastatic breast cancers. Cancer Res 2005;65:3011-6. (Pubitemid 40524576)
25. Li Y, Lin AW, Zhang X, Wang Y, Wang X, Goodrich DW. Cancer cells and normal cells differ in their requirements for Thoc1. Cancer Res 2007;67:6657-64. (Pubitemid 47105511)
26. Li CQ, Kim MY, Godoy LC, Thiantanawat A, Trudel LJ, Wogan GN. Nitric oxide activation of Keap1/Nrf2 signaling in human colon carcinoma cells. Proc Natl Acad Sci USA 2009;106:14547-51.
27. Garay RP, Viens P, Bauer J, Normier G, Bardou M, Jeannin JF, et al. Cancer relapse under chemotherapy: why TLR2/4 receptor agonists can help. Eur J Pharmacol 2007;563:1-17. (Pubitemid 46628799)
28. Doostzadeh-Cizeron J, Evans R, Yin S, Goodrich DW. Apoptosis induced by the nuclear death domain protein p84N5 is inhibited by association with Rb protein. Mol Biol Cell 1999;10:3251-61. (Pubitemid 29489559)
29. Yin S, Hung MC, Goodrich DW. Adenovirus-mediated N5 gene transfer inhibits tumor cell proliferation by induction of apoptosis. Cancer Gene Ther 2000;7: 985-90. (Pubitemid 30483477)
30. Yin S, Bailiang W, Xie K, Goodrich DW. Adenovirus-mediated N5 gene transfer inhibits tumor growth and metastasis of human carcinoma in nude mice. Cancer Gene Ther 2002;9:665-72. (Pubitemid 34847574)
31. Duan Z, Weinstein EJ, Ji D, Ames RY, Choy E, Mankin H, et al. Lentiviral short hairpin RNA screen of genes associated with multidrug resistance identifies PRP-4 as a new regulator of chemoresistance in human ovarian cancer. Mol Cancer Ther 2008;7:2377-85.
32. Nguyen T, Huang HC, Pickett CB. Transcriptional regulation of the antioxidant response element Activation by Nrf2 and repression by MafK. J Biol Chem 2000;275:15466-73. (Pubitemid 30337278)
33. Nioi P, McMahon M, Itoh K, Yamamoto M, Hayes JD. Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:- quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence. Biochem J 2003;374:337-48. (Pubitemid 37094093)
34. Giudice A, Montella M. Activation of the Nrf2-ARE signaling pathway: a promising strategy in cancer prevention. Bioessays 2006;28:169-81.
35. Wang K, Fang H, Xiao D, Zhu X, He M, Pan X, et al. Converting redox signaling to apoptotic activities by stress-responsive regulators HSF1 and NRF2 in fenretinide treated cancer cells. PLoS One 2009;4:e7538.
36. Bat-Chen W, Golan T, Peri I, Ludmer Z, Schwartz B. Allicin purified from fresh garlic cloves induces apoptosis in colon cancer cells via Nrf2. Nutr Cancer 2010;62:947-57.
37. Birringer M. Hormetics: dietary triggers of an adaptive stress response. Pharm Res 2011;28:2680-94.